Menarini Silicon Biosystems offers the new CELLSEARCH® Circulating Multiple Myeloma Cell (CMMC) Enumeration assay, the first-of-its-kind LDT, which directly measures levels of plasma cells in peripheral blood. The CELLSEARCH® CMMC enumeration test provides new, complementary information to that of the bone marrow biopsy and other standard-of-care measures. Due to its minimally invasive nature, the test serially monitors plasma cell burden over time without requiring repeated bone marrow biopsies. Through our groundbreaking technology platforms and global lab services, we have standardized serial monitoring through cell-based liquid biopsy for a variety of conditions.